Slipped Capital Femoral Epiphysis Associated with Endocrinopathy
K. Aaron Shaw, A. Luke Shiver, Tannur Oakes, Nicholas D. Fletcher
Abstract
»: Slipped capital femoral epiphysis (SCFE) has a well-documented association with underlying endocrine conditions, including thyroid hormone aberrations and parathyroid dysfunction. »: Recombinant growth hormone therapy has also been identified as a risk factor for the development of SCFE. »: Presentation before their 10th birthday or after their 16th birthday along with height of <10th percentile are reliable risk factors for identifying children with an SCFE who are at a heightened risk for an underlying endocrinopathy and can been used to guide selective laboratory testing. »: Patients with unilateral SCFE presentations with an underlying endocrinopathy are at a heightened risk for contralateral slip development and should be treated with prophylactic fixation.